We invite you to join us for this one-day meeting that will address the latest strategies and state-of-the-art approaches for managing lung cancer. The Atlanta Lung Cancer Symposium (ALCS), now in its thirteenth year, is a pioneering educational program that incorporates a multidisciplinary approach to presenting the most current literature and research related to lung cancer patient care. This is accomplished by four means: (1) engaging top lung cancer experts as faculty, whose research and practices are at the cutting edge of lung cancer treatment; (2) collaboration between these experts and the meeting co-chairs to generate an agenda that highlights emerging therapies and recent data; (3) utilizing plenary sessions; and (4) incorporating panel discussions as well as question and answer periods.
To provide optimal care for patients with lung cancer, clinicians must continually evaluate novel treatment options and implement best practices regarding diagnosis and treatment. The latest clinical trial data and practice guidelines need to be routinely assessed and reviewed in order to be current and most impactful to the patient. Practitioners attending ALCS will emerge from the program updated on recent data and armed with new tools to help them improve clinical outcomes.
This activity is jointly provided by SynAptiv and Phillips Gilmore Oncology Communications, Inc. This meeting has been planned and will be implemented in accordance with the Essential Areas and Policies of the ACCME. CME, CNE, and ACPE credit will be offered
1065 Peachtree St NE
Atlanta, GA 30309
Phone: (404) 745-5000
Hotel accommodations for symposium attendees are available at the Loews Atlanta Hotel at a rate of $259/night. Mention the symposium when you make your reservation.
BREAKFAST SPONSOR: Bayer
LUNCH SPONSOR: PharmaMar
This activity is supported by educational grants from Merck and Pfizer.